Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.
Massive Bio Inc., a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI).
- Massive Bio Inc., a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI).
- View the full release here: https://www.businesswire.com/news/home/20231003735216/en/
Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.; Elevating Global Patient Access to Clinical Trials through Revolutionary Collaboration and Advanced AI-Driven Technologies (Photo: Business Wire)
Strategic Synergy for Clinical Trials:
Massive Bio’s unwavering dedication to revolutionizing clinical trial recruitment is accentuated by its strategic alignment with Evernorth Health, Inc. - "Our endeavor to radically revamp the clinical trial recruitment landscape and democratize access to advanced care is substantially bolstered through our relationship with Evernorth Health, Inc.," stated Selin Kurnaz , CEO of Massive Bio.
- Massive Bio is a global leader in digital health tech, steadfastly committed to innovating the clinical trial recruitment paradigm through pioneering solutions and avant-garde technologies.